Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
- PMID: 32203186
- PMCID: PMC7091621
- DOI: 10.1038/s41423-020-0401-3
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
Conflict of interest statement
The authors declare no competing interests.
Figures

Comment on
-
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Lancet. 2020. PMID: 31986264 Free PMC article.
Similar articles
-
SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.Cytometry A. 2020 Apr;97(4):340-343. doi: 10.1002/cyto.a.24002. Epub 2020 Mar 18. Cytometry A. 2020. PMID: 32187834 Free PMC article. No abstract available.
-
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.J Immunother Cancer. 2020 Jul;8(2):e000862. doi: 10.1136/jitc-2020-000862. J Immunother Cancer. 2020. PMID: 32727811 Free PMC article.
-
The progression of computed tomographic (CT) images in patients with coronavirus disease (COVID-19) pneumonia: Running title: The CT progression of COVID-19 pneumonia.J Infect. 2020 Jun;80(6):e30-e31. doi: 10.1016/j.jinf.2020.03.020. Epub 2020 Mar 20. J Infect. 2020. PMID: 32205140 Free PMC article.
-
COVID-19: in the absence of vaccination - 'mask the nation'.Future Microbiol. 2020 Jul;15:963-966. doi: 10.2217/fmb-2020-0112. Epub 2020 Jul 17. Future Microbiol. 2020. PMID: 32677846 Free PMC article. No abstract available.
-
Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.Travel Med Infect Dis. 2020 Jul-Aug;36:101625. doi: 10.1016/j.tmaid.2020.101625. Epub 2020 Mar 14. Travel Med Infect Dis. 2020. PMID: 32184131 Free PMC article.
Cited by
-
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019.Eur J Cancer. 2020 Aug;135:62-65. doi: 10.1016/j.ejca.2020.05.026. Epub 2020 Jun 4. Eur J Cancer. 2020. PMID: 32544799 Free PMC article.
-
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.J Med Case Rep. 2020 Oct 15;14(1):187. doi: 10.1186/s13256-020-02503-9. J Med Case Rep. 2020. PMID: 33054818 Free PMC article.
-
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.J Clin Invest. 2020 Dec 1;130(12):6290-6300. doi: 10.1172/JCI140335. J Clin Invest. 2020. PMID: 32784290 Free PMC article. Clinical Trial.
-
Risk stratification by long non-coding RNAs profiling in COVID-19 patients.J Cell Mol Med. 2021 May;25(10):4753-4764. doi: 10.1111/jcmm.16444. Epub 2021 Mar 23. J Cell Mol Med. 2021. PMID: 33759345 Free PMC article.
-
Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation.Kidney Int. 2021 Oct;100(4):915-927. doi: 10.1016/j.kint.2021.05.032. Epub 2021 Jun 11. Kidney Int. 2021. PMID: 34126110 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical